Amedeo Smart

Free Medical Literature Service

 

Amedeo

Influenza
  Free Subscription

Articles published in
JAMA
    September 2025
  1. RUDMAN SPERGEL AK, Callendret B, Kostanyan L
    Influenza and COVID-19 Multicomponent Vaccine in Adults-Reply.
    JAMA. 2025 Sep 8. doi: 10.1001/jama.2025.12225.
    >> Share

  2. LIU Z, Zhang L, Jiang M
    Influenza and COVID-19 Multicomponent Vaccine in Adults.
    JAMA. 2025 Sep 8. doi: 10.1001/jama.2025.12222.
    >> Share

    August 2025
  3. LASSEN MCH, Johansen ND, Christensen SH, Aliabadi N, et al
    Bivalent RSV Prefusion F Protein-Based Vaccine for Preventing Cardiovascular Hospitalizations in Older Adults: A Prespecified Analysis of the DAN-RSV Trial.
    JAMA. 2025 Aug 30:e2515405. doi: 10.1001/jama.2025.15405.
    >> Share

  4. SURIE D, Self WH, Yuengling KA, Lauring AS, et al
    RSV Vaccine Effectiveness Against Hospitalization Among US Adults Aged 60 Years or Older During 2 Seasons.
    JAMA. 2025 Aug 30:e2515896. doi: 10.1001/jama.2025.15896.
    >> Share

    July 2025
  5. UYEKI TM
    Pediatric Influenza-Associated Acute Necrotizing Encephalopathy-Gaps Need to Be Addressed.
    JAMA. 2025 Jul 30. doi: 10.1001/jama.2025.13003.
    >> Share

  6. SILVERMAN A, Walsh R, Santoro JD, Thomas K, et al
    Influenza-Associated Acute Necrotizing Encephalopathy in US Children.
    JAMA. 2025 Jul 30:e2511534. doi: 10.1001/jama.2025.11534.
    >> Share

    May 2025
  7. RUDMAN SPERGEL AK, Wu I, Deng W, Cardona J, et al
    Immunogenicity and Safety of Influenza and COVID-19 Multicomponent Vaccine in Adults >/=50 Years: A Randomized Clinical Trial.
    JAMA. 2025 May 7:e255646. doi: 10.1001/jama.2025.5646.
    >> Share

    April 2025
  8. MOIN EE, Seewald NJ, Halpern SD
    Use of Life Support and Outcomes Among Patients Admitted to Intensive Care Units.
    JAMA. 2025 Apr 14:e252163. doi: 10.1001/jama.2025.2163.
    >> Share

    February 2025
  9. WU PH, Ho YY, Chang CM
    Electronic Nudges for Influenza Vaccination.
    JAMA. 2025 Feb 10. doi: 10.1001/jama.2024.26532.
    >> Share

  10. JOHANSEN ND, Biering-Sorensen T
    Electronic Nudges for Influenza Vaccination-Reply.
    JAMA. 2025 Feb 10. doi: 10.1001/jama.2024.26535.
    >> Share

    January 2025
  11. BOCK A
    CDC Advises Expedited Influenza Subtyping in Hospitalized Patients to Help Identify Bird Flu Cases Sooner.
    JAMA. 2025 Jan 31. doi: 10.1001/jama.2025.0679.
    >> Share

    December 2024
  12. ANDERER S
    CDC Calls Attention to Underuse of Antiviral Treatment in Higher-Risk Youth With Influenza.
    JAMA. 2024 Dec 27. doi: 10.1001/jama.2024.25515.
    >> Share

  13. GENG LN, Erlandson KM, Hornig M, Letts R, et al
    2024 Update of the RECOVER-Adult Long COVID Research Index.
    JAMA. 2024 Dec 18. doi: 10.1001/jama.2024.24184.
    >> Share

  14. MAIA IS, Kawano-Dourado L, Tramujas L, de Oliveira NE, et al
    High-Flow Nasal Oxygen vs Noninvasive Ventilation in Patients With Acute Respiratory Failure: The RENOVATE Randomized Clinical Trial.
    JAMA. 2024 Dec 10. doi: 10.1001/jama.2024.26244.
    >> Share

    October 2024
  15. TADROUS M, Callaway Kim K, Hernandez I, Rothenberger SD, et al
    Differences in Drug Shortages in the US and Canada.
    JAMA. 2024 Oct 31. doi: 10.1001/jama.2024.17688.
    >> Share


  16. Audio Highlights: September 14-20, 2024.
    JAMA. 2024;332:e2318402.
    >> Share

  17. HABIB AR, Ijaz N
    Public Health Crisis in Gaza-Reply.
    JAMA. 2024;332:1305-1306.
    >> Share

  18. JOHANSEN ND, Vaduganathan M, Bhatt AS, Modin D, et al
    Electronic Nudges to Increase Influenza Vaccination in Patients With Chronic Diseases: A Randomized Clinical Trial.
    JAMA. 2024 Oct 11. doi: 10.1001/jama.2024.21060.
    >> Share

    September 2024
  19. AMBA V, Cooper MSL, Sommers BD
    History Repeats-The Election Battle for Medicaid in 2024.
    JAMA. 2024;332:867-868.
    >> Share

  20. RUBIN R
    The Latest Research About Paxlovid: Effectiveness, Access, and Possible Long COVID Benefits.
    JAMA. 2024 Sep 6. doi: 10.1001/jama.2024.16432.
    >> Share

  21. GOODMAN JL, Bright RA, Lurie N
    H5 Influenza Vaccines-Moving Forward Against Pandemic Threats.
    JAMA. 2024 Sep 4. doi: 10.1001/jama.2024.17488.
    >> Share

  22. SURIE D, Self WH, Zhu Y, Yuengling KA, et al
    RSV Vaccine Effectiveness Against Hospitalization Among US Adults 60 Years and Older.
    JAMA. 2024 Sep 4:e2415775. doi: 10.1001/jama.2024.15775.
    >> Share


  23. Audio Highlights.
    JAMA. 2024;332:e2318388.
    >> Share

    August 2024
  24. WOOLF SH
    Increasing Mortality Rates in the US, but Not From COVID-19.
    JAMA. 2024 Aug 29. doi: 10.1001/jama.2024.13626.
    >> Share

  25. AHMAD FB, Cisewski JA, Anderson RN
    Leading Causes of Death in the US, 2019-2023.
    JAMA. 2024 Aug 8. doi: 10.1001/jama.2024.15563.
    >> Share

  26. HARRIS E
    Does Infectious Bird Flu Virus Persist After Pasteurization?
    JAMA. 2024;332:362.
    >> Share

  27. HARRIS E
    NIH Starts Testing Nasal COVID-19 Vaccine in US.
    JAMA. 2024 Aug 2. doi: 10.1001/jama.2024.13769.
    >> Share

    July 2024
  28. HARRIS E
    CDC Revises RSV Vaccination Recommendation for Older Adults in US.
    JAMA. 2024 Jul 26. doi: 10.1001/jama.2024.13385.
    >> Share

  29. HARRIS E
    COVID-19 Vaccination in Early Pregnancy Not Linked to Birth Defects.
    JAMA. 2024 Jul 26. doi: 10.1001/jama.2024.13389.
    >> Share

  30. YOUMSHAJEKIAN L
    COVID-19 May Protect Against the Common Cold-Here's Why Knowing That Could Lead to Better Vaccines.
    JAMA. 2024 Jul 26. doi: 10.1001/jama.2024.13382.
    >> Share

  31. ABBASI J
    As a Third Worker Tests Positive for Bird Flu in US Dairy Cattle Outbreak, Here's What to Know.
    JAMA. 2024;332:267-269.
    >> Share

  32. AGARWAL SD, Cook BL, Liebman JB
    Effect of Cash Benefits on Health Care Utilization and Health: A Randomized Study.
    JAMA. 2024 Jul 22:e2413004. doi: 10.1001/jama.2024.13004.
    >> Share

  33. FRIEDL N, Sporreiter M, Winkler C, Heublein A, et al
    Progression From Presymptomatic to Clinical Type 1 Diabetes After COVID-19 Infection.
    JAMA. 2024 Jul 15:e2411174. doi: 10.1001/jama.2024.11174.
    >> Share

  34. HARRIS E
    Symptoms After COVID-19 Vaccination Tied to Higher Antibody Levels.
    JAMA. 2024 Jul 12. doi: 10.1001/jama.2024.12231.
    >> Share

  35. RUBIN R
    Picking the Optimal Variant to Target in Updated COVID-19 Vaccines Is Tricky.
    JAMA. 2024 Jul 12. doi: 10.1001/jama.2024.10992.
    >> Share

  36. HARRIS E
    Review Calls for Standardized Long COVID Definition.
    JAMA. 2024;332:97.
    >> Share

  37. FANG Z, Ahrnsbrak R, Rekito A
    Evidence Mounts That About 7% of US Adults Have Had Long COVID.
    JAMA. 2024;332:5-6.
    >> Share

    June 2024
  38. SCRUGGS-WODKOWSKI EA, Malani PN, Linder KA
    Therapies to Decrease Severe Respiratory Syncytial Virus Illness.
    JAMA. 2024;331:2127-2128.
    >> Share

  39. ZIMBROFF RM, Deardorff WJ, Song S, Nikolov MC, et al
    Use of a Financial Incentive Code for In-Home COVID-19 Vaccination of Homebound Older Adults.
    JAMA. 2024 Jun 20. doi: 10.1001/jama.2024.9673.
    >> Share

  40. PIRRACCHIO R, Venkatesh B, Legrand M
    Low-Dose Corticosteroids for Critically Ill Adults With Severe Pulmonary Infections: A Review.
    JAMA. 2024 Jun 12. doi: 10.1001/jama.2024.6096.
    >> Share

  41. VAN DER LINDEN S, Roozenbeek J
    "Inoculation" to Resist Misinformation.
    JAMA. 2024;331:1961-1962.
    >> Share

  42. ABBASI J
    Bird Flu Outbreak in Dairy Cows Is Widespread, Raising Public Health Concerns.
    JAMA. 2024;331:1789-1791.
    >> Share

  43. ANGUS DC, Huang AJ, Lewis RJ, Abernethy AP, et al
    The Integration of Clinical Trials With the Practice of Medicine: Repairing a House Divided.
    JAMA. 2024 Jun 3. doi: 10.1001/jama.2024.4088.
    >> Share

    May 2024
  44. HARRIS E
    Monoclonal Antibody Authorized to Protect At-Risk People From COVID-19.
    JAMA. 2024 May 24. doi: 10.1001/jama.2024.8628.
    >> Share

  45. HARRIS E
    Lower Dose of Mpox Vaccine Was Safe, Effective.
    JAMA. 2024 May 24. doi: 10.1001/jama.2024.8635.
    >> Share

  46. KOJIMA N, Blumberg A, Radcliffe R, Flannery B, et al
    US Public Health Preparedness and Response to Highly Pathogenic Avian Influenza A(H5N1) Viruses.
    JAMA. 2024 May 21:e2410116. doi: 10.1001/jama.2024.10116.
    >> Share

  47. BOCK A
    Researchers See Hope in Symptom-Guided Exercise for Long COVID With Postexertional Malaise.
    JAMA. 2024;331:1609-1611.
    >> Share

  48. HARRIS E
    CDC: H5N1 Bird Flu Confirmed in Person Exposed to Cattle.
    JAMA. 2024;331:1615.
    >> Share

  49. RUBIN R
    Combined Vaccines Against COVID-19, Flu, and Other Respiratory Illnesses Could Soon Be Available.
    JAMA. 2024 May 17. doi: 10.1001/jama.2024.7370.
    >> Share

  50. XIE Y, Choi T, Al-Aly Z
    Mortality in Patients Hospitalized for COVID-19 vs Influenza in Fall-Winter 2023-2024.
    JAMA. 2024 May 15:e247395. doi: 10.1001/jama.2024.7395.
    >> Share


  51. Audio Highlights.
    JAMA. 2024;331:e2318283.
    >> Share

  52. WEN X, Yan J, Zhu Z
    Apixaban to Prevent Recurrence After Cryptogenic Stroke.
    JAMA. 2024 May 13. doi: 10.1001/jama.2024.6848.
    >> Share

  53. HARRIS E
    National Academies Report: COVID-19 Vaccines Don't Cause Many Potential Harms.
    JAMA. 2024 May 10. doi: 10.1001/jama.2024.7724.
    >> Share

  54. HARRIS E
    Trials Will Evaluate Treatments for Long COVID Nervous System Problems.
    JAMA. 2024;331:1439-1440.
    >> Share

  55. AGRAWAL S, Ross JS, Ramachandran R
    Implications for Public Health Regulation if Chevron Deference Is Overturned.
    JAMA. 2024;331:1443-1444.
    >> Share

  56. CHESHIRE WP, Dudenkov DV, Munipalli B
    Tilt Table Testing.
    JAMA. 2024;331:1494-1495.
    >> Share

    April 2024
  57. HARRIS E
    WHO Launches Broad Coronavirus Surveillance Network.
    JAMA. 2024 Apr 26. doi: 10.1001/jama.2024.6724.
    >> Share

  58. ALLEN MR, Desai N, Namazi A, Leas E, et al
    Characteristics of X (Formerly Twitter) Community Notes Addressing COVID-19 Vaccine Misinformation.
    JAMA. 2024 Apr 24:e244800. doi: 10.1001/jama.2024.4800.
    >> Share

  59. HARRIS E
    Meta-Analysis: "Limited" Benefits to Rapid Viral Tests in EDs.
    JAMA. 2024;331:1355.
    >> Share

  60. HARRIS E
    Deaths From Excessive Drinking Rose in the US During Pandemic.
    JAMA. 2024;331:1355.
    >> Share

  61. HARRIS E
    Antidepressant Prescriptions for Female Teens Surged After Pandemic.
    JAMA. 2024;331:1266.
    >> Share

  62. ANDERER S
    Could "Empathetic Refutation" Help Clinicians Sway Vaccine Skeptics?
    JAMA. 2024 Apr 12. doi: 10.1001/jama.2024.4493.
    >> Share

  63. HARRIS E
    COVID-19 Vaccination Linked With Lower Risk of Cardiac Problems.
    JAMA. 2024 Apr 12. doi: 10.1001/jama.2024.5152.
    >> Share

  64. HARRIS E
    Safety Concerns Put a Stop to Maternal RSV Vaccine Study.
    JAMA. 2024 Apr 12. doi: 10.1001/jama.2024.5155.
    >> Share

  65. DAWOOD FS, Payne AB, McMorrow ML
    Assessing the Real-World Effectiveness of Immunizations for Respiratory Syncytial Virus.
    JAMA. 2024 Apr 11. doi: 10.1001/jama.2024.5859.
    >> Share

  66. ANDERER S
    Study: 1 of Every 9 US Cancer Cases Missed During 2020 Pandemic.
    JAMA. 2024;331:1082.
    >> Share

    March 2024
  67. HARRIS E
    COVID-19 Infection Tied to Slight Cognitive Deficits.
    JAMA. 2024 Mar 22. doi: 10.1001/jama.2024.2087.
    >> Share

  68. HARRIS E
    COVID-19 Associated With Higher Risk of Autoimmune Diseases.
    JAMA. 2024 Mar 22. doi: 10.1001/jama.2024.2092.
    >> Share

  69. LU Y, Matuska K, Nadimpalli G, Ma Y, et al
    Stroke Risk After COVID-19 Bivalent Vaccination Among US Older Adults.
    JAMA. 2024;331:938-950.
    >> Share

  70. HARRIS E
    CDC Tracking BA.2.87.1, New Omicron Subvariant With Potential to Evade Immunity.
    JAMA. 2024;331:907.
    >> Share

  71. NIELSEN FM, Klitgaard TL, Siegemund M, Laake JH, et al
    Lower vs Higher Oxygenation Target and Days Alive Without Life Support in COVID-19: The HOT-COVID Randomized Clinical Trial.
    JAMA. 2024 Mar 19:e242934. doi: 10.1001/jama.2024.2934.
    >> Share

  72. SCHWARTZSTEIN RM
    Oxygen Supplementation in COVID-19-How Much Is Enough?
    JAMA. 2024 Mar 19. doi: 10.1001/jama.2024.2935.
    >> Share

  73. ANDERER S
    CDC Recommends Additional COVID-19 Booster for Older Adults.
    JAMA. 2024 Mar 13. doi: 10.1001/jama.2024.2071.
    >> Share

  74. MCKENZIE C, Moore L, Borthwick M
    Vitamin C for Patients Hospitalized With COVID-19.
    JAMA. 2024;331:886.
    >> Share

  75. ADHIKARI NKJ, Lamontagne F
    Vitamin C for Patients Hospitalized With COVID-19-Reply.
    JAMA. 2024;331:886-887.
    >> Share

  76. HARRIS E
    Virtual Group Exercise Program Improved Long COVID Symptoms.
    JAMA. 2024;331:822.
    >> Share

  77. HARRIS E
    Better Outcomes When Kidney Damage Is From COVID-19.
    JAMA. 2024 Mar 6. doi: 10.1001/jama.2024.1574.
    >> Share

  78. HARRIS E
    HPV Vaccination Rates Stagnated During COVID-19 Pandemic.
    JAMA. 2024 Mar 6. doi: 10.1001/jama.2024.1569.
    >> Share

  79. HARRIS E
    Millions of US Children Experience Range of Long COVID Effects.
    JAMA. 2024;331:726.
    >> Share

    February 2024
  80. ANDERSSON NW, Thiesson EM, Hviid A
    Adverse Events After XBB.1.5-Containing COVID-19 mRNA Vaccines.
    JAMA. 2024 Feb 26:e241036. doi: 10.1001/jama.2024.1036.
    >> Share

  81. HARRIS E
    New Antiviral on the Horizon for Mild to Moderate COVID-19.
    JAMA. 2024 Feb 21. doi: 10.1001/jama.2024.0729.
    >> Share

  82. GRAETZ N, Hepburn P, Gershenson C, Porter SR, et al
    Examining Excess Mortality Associated With the COVID-19 Pandemic for Renters Threatened With Eviction.
    JAMA. 2024;331:592-600.
    >> Share

  83. RUBIN R
    When It Comes to SARS-CoV-2 Clearance, People Who are Immunocompromised Are Not All Alike.
    JAMA. 2024 Feb 14. doi: 10.1001/jama.2024.1014.
    >> Share

  84. NORMAN M, Magnus MC, Soderling J, Juliusson PB, et al
    Neonatal Outcomes After COVID-19 Vaccination in Pregnancy.
    JAMA. 2024;331:396-407.
    >> Share

  85. FELDSTEIN LR, Britton A, Grant L, Wiegand R, et al
    Effectiveness of Bivalent mRNA COVID-19 Vaccines in Preventing SARS-CoV-2 Infection in Children and Adolescents Aged 5 to 17 Years.
    JAMA. 2024;331:408-416.
    >> Share

    January 2024
  86. HARRIS E
    Missed Vaccine Doses Tied to Worse COVID-19 Outcomes.
    JAMA. 2024 Jan 31. doi: 10.1001/jama.2023.28340.
    >> Share

  87. RUBIN R
    Paxlovid Is Effective but Underused-Here's What the Latest Research Says About Rebound and More.
    JAMA. 2024 Jan 31. doi: 10.1001/jama.2023.28254.
    >> Share

  88. RUBIN R
    As COVID-19 Cases Surge, Here's What to Know About JN.1, the Latest SARS-CoV-2 "Variant of Interest".
    JAMA. 2024 Jan 12. doi: 10.1001/jama.2023.27841.
    >> Share

  89. RUBIN R
    From "Immunity Debt" to "Immunity Theft"-How COVID-19 Might Be Tied to Recent Respiratory Disease Surges.
    JAMA. 2024 Jan 10. doi: 10.1001/jama.2023.26608.
    >> Share

  90. HARRIS E
    High-Dose Flu Vaccine May Be More Effective for Midlife Adults.
    JAMA. 2024 Jan 3. doi: 10.1001/jama.2023.26114.
    >> Share

  91. HARRIS E
    Long COVID in Nursing Home Residents Manifests as Functional Decline.
    JAMA. 2024;331:15.
    >> Share

    December 2023
  92. HARRIS E
    Disproportionate Death Rates Reported in US Prisons Early in the COVID-19 Pandemic.
    JAMA. 2023 Dec 27. doi: 10.1001/jama.2023.25770.
    >> Share

  93. HARRIS E
    Using Throat Swabs Improved Sensitivity in Detecting SARS-CoV-2.
    JAMA. 2023 Dec 20. doi: 10.1001/jama.2023.25267.
    >> Share

  94. HARRIS E
    Program Offering Free COVID-19 and Flu Services Expands Nationwide.
    JAMA. 2023 Dec 20. doi: 10.1001/jama.2023.25268.
    >> Share

  95. HARRIS E
    Life Expectancy in US Climbed After Declines Related to COVID-19.
    JAMA. 2023 Dec 13. doi: 10.1001/jama.2023.24683.
    >> Share

  96. SURAN M
    Studies Investigate Whether Antivirals Like Paxlovid May Prevent Long COVID.
    JAMA. 2023 Dec 13. doi: 10.1001/jama.2023.24103.
    >> Share

  97. RUBIN R
    Up the Nose and Down the Windpipe May Be the Path to New and Improved COVID-19 Vaccines.
    JAMA. 2023 Dec 6. doi: 10.1001/jama.2023.0644.
    >> Share

  98. MATHEW P, Feldmann M
    Treatment of Adults Hospitalized With COVID-19 Pneumonia.
    JAMA. 2023;330:2122-2123.
    >> Share

  99. POWDERLY WG, LaVange L, Bozzette SA
    Treatment of Adults Hospitalized With COVID-19 Pneumonia-Reply.
    JAMA. 2023;330:2123.
    >> Share

    November 2023
  100. EASTMAN Q
    Study Shows Businesses Selling Unapproved Stem Cell Treatments Have Turned to Long COVID.
    JAMA. 2023 Nov 29. doi: 10.1001/jama.2023.23897.
    >> Share

  101. BERGMAN C
    Treatment of SARS-CoV-2 Infection in US Nursing Homes.
    JAMA. 2023;330:2021-2022.
    >> Share

  102. MCGARRY BE, Sommers BD, Barnett ML
    Treatment of SARS-CoV-2 Infection in US Nursing Homes-Reply.
    JAMA. 2023;330:2022.
    >> Share

  103. HARRIS E
    COVID Moonshot Drove Discovery of Potential COVID-19 Antivirals.
    JAMA. 2023 Nov 22. doi: 10.1001/jama.2023.22934.
    >> Share

  104. HARRIS E
    Smell, Taste Issues After Mild COVID-19 Resolve Over 3 Years.
    JAMA. 2023 Nov 22. doi: 10.1001/jama.2023.22930.
    >> Share

  105. HARRIS E
    Long COVID Linked With Viral Persistence, Serotonin Decline.
    JAMA. 2023;330:1827.
    >> Share

  106. HARRIS E
    Audit Finds US National Stockpile "Was Not Equipped" for the Pandemic.
    JAMA. 2023;330:1828.
    >> Share

  107. STEWART TG, Rebolledo PA, Mourad A, Lindsell CJ, et al
    Higher-Dose Fluvoxamine and Time to Sustained Recovery in Outpatients With COVID-19: The ACTIV-6 Randomized Clinical Trial.
    JAMA. 2023 Nov 17:e2323363. doi: 10.1001/jama.2023.23363.
    >> Share

  108. HARRIS E
    Combined COVID-19, Flu Vaccine Candidate Headed to Phase 3 Trials.
    JAMA. 2023 Nov 15. doi: 10.1001/jama.2023.22353.
    >> Share

  109. HARRIS E
    FDA Will Evaluate First Self-Administered FluMist Vaccine.
    JAMA. 2023 Nov 8. doi: 10.1001/jama.2023.21870.
    >> Share

  110. HARRIS E
    Convalescent Plasma Lowered Risk of Death in COVID-19 ARDS.
    JAMA. 2023 Nov 8. doi: 10.1001/jama.2023.21872.
    >> Share

  111. HARRIS E
    HRSA Study: US Abortions Decreased 14% During COVID-19.
    JAMA. 2023 Nov 1. doi: 10.1001/jama.2023.21178.
    >> Share

    October 2023
  112. ADHIKARI NKJ, Hashmi M, Tirupakuzhi Vijayaraghavan BK, Haniffa R, et al
    Intravenous Vitamin C for Patients Hospitalized With COVID-19: Two Harmonized Randomized Clinical Trials.
    JAMA. 2023 Oct 25:e2321407. doi: 10.1001/jama.2023.21407.
    >> Share

  113. JABALEY CS, Coopersmith CM
    Vitamin C for Patients With COVID-19: More Evidence of Lack of Efficacy in Patients With Sepsis.
    JAMA. 2023 Oct 25. doi: 10.1001/jama.2023.18592.
    >> Share

  114. HARRIS E
    US Survey: About 7% of Adults, 1% of Children Have Had Long COVID.
    JAMA. 2023;330:1516.
    >> Share

  115. KOJIMA N, Peterson L, Hawkins R, Allen M, et al
    Influenza Antiviral Shortages Reported by State and Territorial Public Health Officials, 2022-2023.
    JAMA. 2023 Oct 20. doi: 10.1001/jama.2023.17244.
    >> Share

  116. HARRIS E
    COVID-19 Hospitalizations Up Among Older Adults.
    JAMA. 2023 Oct 18. doi: 10.1001/jama.2023.19796.
    >> Share

  117. HARRIS E
    Previous COVID-19 Linked With Autoimmune Conditions.
    JAMA. 2023 Oct 18. doi: 10.1001/jama.2023.19798.
    >> Share

  118. BATRA A, Nath A, Koralnik IJ
    Postacute Sequelae of SARS-CoV-2 Infection.
    JAMA. 2023;330:1491-1492.
    >> Share

  119. THAWEETHAI T, Foulkes AS
    Postacute Sequelae of SARS-CoV-2 Infection-Reply.
    JAMA. 2023;330:1492.
    >> Share

  120. HARRIS E
    Exercise Programs Might Improve Long COVID.
    JAMA. 2023;330:1421.
    >> Share

  121. HARRIS E
    Wastewater Surveillance Predicts Large-Scale Flu, RSV Trends.
    JAMA. 2023;330:1422.
    >> Share

  122. HARRIS E
    Changes in SARS-CoV-2 Sequence Linked With Antiviral Use.
    JAMA. 2023 Oct 4. doi: 10.1001/jama.2023.19202.
    >> Share

    September 2023
  123. HARRIS E
    NIH Launches Phase 1 Trial of Broader "Universal" Flu Vaccine.
    JAMA. 2023 Sep 27. doi: 10.1001/jama.2023.18741.
    >> Share

  124. HARRIS E
    Some People Still Have Long COVID Symptoms After 2 Years.
    JAMA. 2023;330:1127.
    >> Share

  125. RUBIN R
    Updated COVID-19 Vaccine Now Available in US, Recommended for Everyone Older Than 6 Months.
    JAMA. 2023 Sep 18. doi: 10.1001/jama.2023.19759.
    >> Share

  126. TARTOF SY, Frankland TB, Slezak JM, Puzniak L, et al
    Receipt of BNT162b2 Vaccine and COVID-19 Ambulatory Visits in US Children Younger Than 5 Years.
    JAMA. 2023 Sep 15. doi: 10.1001/jama.2023.17473.
    >> Share

  127. HARRIS E
    Two New Analyses Add to Long COVID Understanding.
    JAMA. 2023;330:905-906.
    >> Share

  128. LUGAR M, Eugster A, Achenbach P, von dem Berge T, et al
    SARS-CoV-2 Infection and Development of Islet Autoimmunity in Early Childhood.
    JAMA. 2023 Sep 8. doi: 10.1001/jama.2023.16348.
    >> Share

  129. HARRIS E
    High Blood Pressure More Likely After COVID-19 Than Flu.
    JAMA. 2023 Sep 6. doi: 10.1001/jama.2023.16676.
    >> Share

  130. HARRIS E
    HHS To Invest $1.4 Billion in New COVID-19 Vaccines, Therapies.
    JAMA. 2023 Sep 6. doi: 10.1001/jama.2023.16678.
    >> Share

  131. HARRIS E
    CDC Recommends RSV Immunization for Infants.
    JAMA. 2023;330:797.
    >> Share

  132. HARRIS E
    Federal Government Announces Long COVID Trials, Research Office.
    JAMA. 2023;330:797.
    >> Share

  133. KENTISH-BARNES N, Resche-Rigon M, Lafarge A, Souppart V, et al
    PTSD Symptoms Among Family Members of Patients With ARDS Caused by COVID-19 After 12 Months.
    JAMA. 2023 Sep 1. doi: 10.1001/jama.2023.15879.
    >> Share

    August 2023
  134. HARRIS E
    Severe COVID-19 Linked to Enduring Immune System Changes.
    JAMA. 2023 Aug 30. doi: 10.1001/jama.2023.16109.
    >> Share

  135. HARRIS E
    CDC Assesses Risk From BA.2.86, Highly Mutated COVID-19 Variant.
    JAMA. 2023 Aug 30. doi: 10.1001/jama.2023.16105.
    >> Share

  136. HARRIS E
    FDA Approves Maternal RSV Vaccine.
    JAMA. 2023 Aug 30. doi: 10.1001/jama.2023.16106.
    >> Share

  137. HARRIS E
    Human Infections With Swine Influenza Viruses Identified in US.
    JAMA. 2023 Aug 23. doi: 10.1001/jama.2023.15451.
    >> Share

  138. HARRIS E
    Lung Transplants for COVID-19 Similarly Successful.
    JAMA. 2023 Aug 23. doi: 10.1001/jama.2023.15450.
    >> Share

  139. ABBASI J
    What to Know About EG.5, the Latest SARS-CoV-2 "Variant of Interest".
    JAMA. 2023 Aug 18. doi: 10.1001/jama.2023.16498.
    >> Share

  140. RUBIN R
    Why Blood Type Seems to Be Linked With COVID-19 Risk.
    JAMA. 2023 Aug 16. doi: 10.1001/jama.2023.15996.
    >> Share

  141. RAGLOW Z, Malani PN, Petty LA
    Outpatient Treatment for COVID-19.
    JAMA. 2023 Aug 16. doi: 10.1001/jama.2023.16666.
    >> Share

  142. DOS SANTOS RAS, Taccone FS, Annoni F
    Renin-Angiotensin System Modulation in Adults With COVID-19.
    JAMA. 2023;330:663-664.
    >> Share

  143. SELF WH, DeClercq J, Orr M
    Renin-Angiotensin System Modulation in Adults With COVID-19-Reply.
    JAMA. 2023;330:664-665.
    >> Share

  144. HARRIS E
    FDA Approves RSV Monoclonal Antibody for Infants and Young Children.
    JAMA. 2023;330:586.
    >> Share

  145. ABBASI J
    Vigilance Urged Against Bird Flu Amid Ongoing Outbreaks in Mammals.
    JAMA. 2023;330:583-584.
    >> Share

  146. ABBASI J
    A Genetic Explanation for Why Some People Had Asymptomatic COVID-19.
    JAMA. 2023 Aug 2. doi: 10.1001/jama.2023.14703.
    >> Share

  147. DAVIDSON BL, Levi MM
    Treatment Effects of Therapeutic-Dose Heparin in Patients Hospitalized for COVID-19.
    JAMA. 2023;330:471-472.
    >> Share

  148. GOLIGHER EC, Lawler PR, Zarychanski R
    Treatment Effects of Therapeutic-Dose Heparin in Patients Hospitalized for COVID-19-Reply.
    JAMA. 2023;330:472-473.
    >> Share

    July 2023
  149. SURAN M
    HHS Urges Primary Care Clinicians to Help Patients Manage Long COVID's Mental Health Symptoms.
    JAMA. 2023 Jul 26. doi: 10.1001/jama.2023.13605.
    >> Share

  150. HARRIS E
    Free COVID-19 Vaccinations on the Way for Uninsured Adults.
    JAMA. 2023 Jul 26. doi: 10.1001/jama.2023.13133.
    >> Share

  151. GLEASON JL, Tamburro R, Signore C
    Promoting Data Harmonization of COVID-19 Research in Pregnant and Pediatric Populations.
    JAMA. 2023 Jul 20. doi: 10.1001/jama.2023.10835.
    >> Share

  152. MCGARRY BE, Sommers BD, Wilcock AD, Grabowski DC, et al
    Monoclonal Antibody and Oral Antiviral Treatment of SARS-CoV-2 Infection in US Nursing Homes.
    JAMA. 2023 Jul 14:e2312945. doi: 10.1001/jama.2023.12945.
    >> Share

  153. O'HALLORAN JA, Ko ER, Anstrom KJ, Kedar E, et al
    Abatacept, Cenicriviroc, or Infliximab for Treatment of Adults Hospitalized With COVID-19 Pneumonia: A Randomized Clinical Trial.
    JAMA. 2023 Jul 10:e2311043. doi: 10.1001/jama.2023.11043.
    >> Share

  154. RUBIN R
    This Fall's COVID-19 Vaccines Will Target Omicron XBB Subvariants, but Who Needs Them Remains to Be Seen.
    JAMA. 2023 Jul 5. doi: 10.1001/jama.2023.10053.
    >> Share

    June 2023
  155. HARRIS E
    Patients With COVID-19 and Fungal Infections Had High Mortality Rates.
    JAMA. 2023 Jun 28. doi: 10.1001/jama.2023.11957.
    >> Share

  156. MICHAELS D, Wagner GR, Ryan L
    Lessons From COVID-19 for Protecting Workers in the Next Pandemic.
    JAMA. 2023 Jun 16. doi: 10.1001/jama.2023.8229.
    >> Share

  157. ANDREWS N, Stowe J, Miller E, Ramsay M, et al
    BA.1 Bivalent COVID-19 Vaccine Use and Stroke in England.
    JAMA. 2023 Jun 15. doi: 10.1001/jama.2023.10123.
    >> Share

  158. HARRIS E
    Hybrid COVID-19 Immunity Common by Fall of 2022.
    JAMA. 2023 Jun 14. doi: 10.1001/jama.2023.10399.
    >> Share

  159. HARRIS E
    Consistent Exercise Tied to Lower Risk of Death From Flu, Pneumonia.
    JAMA. 2023;329:1907-1908.
    >> Share

  160. HARRIS E
    FDA Grants Full Approval to Paxlovid, COVID-19 Antiviral Treatment.
    JAMA. 2023 Jun 7. doi: 10.1001/jama.2023.9925.
    >> Share

    May 2023
  161. THAWEETHAI T, Jolley SE, Karlson EW, Levitan EB, et al
    Development of a Definition of Postacute Sequelae of SARS-CoV-2 Infection.
    JAMA. 2023 May 25:e238823. doi: 10.1001/jama.2023.8823.
    >> Share

  162. GROSS R, Lo Re V 3rd
    Disentangling the Postacute Sequelae of SARS-CoV-2: E Unibus Pluram (From One, Many).
    JAMA. 2023 May 25. doi: 10.1001/jama.2023.8961.
    >> Share

  163. HARRIS E
    CDC Updates COVID-19 Data Reporting as US Public Health Emergency Ends.
    JAMA. 2023 May 24. doi: 10.1001/jama.2023.9150.
    >> Share

  164. WEISS A, Donnachie E, Beyerlein A, Ziegler AG, et al
    Type 1 Diabetes Incidence and Risk in Children With a Diagnosis of COVID-19.
    JAMA. 2023 May 22:e238674. doi: 10.1001/jama.2023.8674.
    >> Share

  165. HARRIS E
    WHO Declares End of COVID-19 Global Health Emergency.
    JAMA. 2023 May 17. doi: 10.1001/jama.2023.8656.
    >> Share

  166. HARRIS E
    COVID-19 Vaccine and Health Care Visits for Menstrual Changes.
    JAMA. 2023 May 17. doi: 10.1001/jama.2023.8658.
    >> Share

  167. HARRIS E
    FDA Clears RSV Vaccine for Adults Aged 60 Years or Older.
    JAMA. 2023 May 17. doi: 10.1001/jama.2023.8657.
    >> Share

  168. ASHRAF S, Ashraf N
    Fluvoxamine vs Placebo and Time to Recovery in Outpatients With Mild to Moderate COVID-19.
    JAMA. 2023;329:1702.
    >> Share

  169. MCCARTHY MW, Lindsell CJ, Naggie S
    Fluvoxamine vs Placebo and Time to Recovery in Outpatients With Mild to Moderate COVID-19-Reply.
    JAMA. 2023;329:1702-1703.
    >> Share

  170. MARCUS R
    New Alzheimer Disease Drugs, Long COVID and the Central Nervous System, and a Nasal Spray for Migraines-Highlights From the 2023 American Academy of Neurology Conference.
    JAMA. 2023 May 10. doi: 10.1001/jama.2023.4389.
    >> Share

  171. HARRIS E
    RSV Infection Might Be Resuming Prepandemic Patterns.
    JAMA. 2023;329:1544.
    >> Share

  172. HARRIS E
    BCG Vaccine Not Effective Against COVID-19.
    JAMA. 2023 May 3. doi: 10.1001/jama.2023.7763.
    >> Share

  173. HARRIS E
    RSV Infection During Infancy Tied to Asthma Later.
    JAMA. 2023 May 3. doi: 10.1001/jama.2023.7765.
    >> Share

  174. HARRIS E
    XBB.1.16 Deemed COVID-19 "Variant of Interest".
    JAMA. 2023 May 3. doi: 10.1001/jama.2023.7768.
    >> Share

  175. LANDHUIS EW
    How Primary Care Physicians Can Recognize and Treat Long COVID.
    JAMA. 2023 May 3. doi: 10.1001/jama.2023.6604.
    >> Share

  176. BOMMERSBACH TJ, McKean AJ, Olfson M, Rhee TG, et al
    National Trends in Mental Health-Related Emergency Department Visits Among Youth, 2011-2020.
    JAMA. 2023;329:1469-1477.
    >> Share

    April 2023
  177. HARRIS E
    WHO: Confirmed Avian Influenza Death in China.
    JAMA. 2023 Apr 26. doi: 10.1001/jama.2023.6622.
    >> Share

  178. HARRIS E
    FDA Simplifies COVID-19 Vaccination, Permits Some Additional Doses.
    JAMA. 2023 Apr 26. doi: 10.1001/jama.2023.6624.
    >> Share

  179. HARRIS E
    How Parents' Views Are Tied to Children's COVID-19 Vaccination.
    JAMA. 2023 Apr 19. doi: 10.1001/jama.2023.6292.
    >> Share

  180. HARRIS E
    RSV Vaccine, Monoclonal Antibody Safe, Effective in Phase 3 Trials.
    JAMA. 2023 Apr 12. doi: 10.1001/jama.2023.6254.
    >> Share

  181. HARRIS E
    Updated WHO Guidance for Prioritizing COVID-19 Vaccines.
    JAMA. 2023 Apr 12. doi: 10.1001/jama.2023.6256.
    >> Share

  182. LEE MMY, McMurray JJV
    Lack of Benefit of Renin-Angiotensin System Inhibitors in COVID-19.
    JAMA. 2023;329:1155-1156.
    >> Share

  183. SELF WH, Shotwell MS, Gibbs KW, de Wit M, et al
    Renin-Angiotensin System Modulation With Synthetic Angiotensin (1-7) and Angiotensin II Type 1 Receptor-Biased Ligand in Adults With COVID-19: Two Randomized Clinical Trials.
    JAMA. 2023;329:1170-1182.
    >> Share

  184. LAWLER PR, Derde LPG, van de Veerdonk FL, McVerry BJ, et al
    Effect of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Initiation on Organ Support-Free Days in Patients Hospitalized With COVID-19: A Randomized Clinical Trial.
    JAMA. 2023;329:1183-1196.
    >> Share

  185. XIE Y, Choi T, Al-Aly Z
    Risk of Death in Patients Hospitalized for COVID-19 vs Seasonal Influenza in Fall-Winter 2022-2023.
    JAMA. 2023 Apr 6. doi: 10.1001/jama.2023.5348.
    >> Share

  186. HARRIS E
    Study: US COVID-19 Outcomes Tied to State Characteristics and Policies.
    JAMA. 2023 Apr 5. doi: 10.1001/jama.2023.5622.
    >> Share

  187. AMMIRATI E, Moslehi JJ
    Diagnosis and Treatment of Acute Myocarditis: A Review.
    JAMA. 2023;329:1098-1113.
    >> Share

  188. HARRIS E
    Public Had Most Trust in Advice From Physicians, Nurses During Pandemic.
    JAMA. 2023;329:1053.
    >> Share

  189. HARRIS E
    "Living" Systematic Review of Mental Health During Pandemic.
    JAMA. 2023;329:1054.
    >> Share

  190. HARRIS E
    Human Flu Cases in Cambodia Not Due to Bird Flu Outbreak Viruses.
    JAMA. 2023;329:1053.
    >> Share

  191. ESMAIL LC, Kapp P, Assi R, Wood J, et al
    Sharing of Individual Patient-Level Data by Trialists of Randomized Clinical Trials of Pharmacological Treatments for COVID-19.
    JAMA. 2023 Apr 3:e234590. doi: 10.1001/jama.2023.4590.
    >> Share

    March 2023
  192. HARRIS E
    Cold Virus Provided Cross-reactivity Against SARS-CoV-2 in Children.
    JAMA. 2023 Mar 29. doi: 10.1001/jama.2023.5261.
    >> Share

  193. CAMPO R
    Illness Metaphors and COVID-19.
    JAMA. 2023;329:1035.
    >> Share

  194. HARRIS E
    Nasally Administered Monoclonal Antibody for COVID-19.
    JAMA. 2023 Mar 22. doi: 10.1001/jama.2023.4000.
    >> Share

  195. LONDON AJ, Seymour CW
    The Ethics of Clinical Research: Managing Persistent Uncertainty.
    JAMA. 2023;329:884-885.
    >> Share

  196. GOLIGHER EC, Lawler PR, Jensen TP, Talisa V, et al
    Heterogeneous Treatment Effects of Therapeutic-Dose Heparin in Patients Hospitalized for COVID-19.
    JAMA. 2023 Mar 21. doi: 10.1001/jama.2023.3651.
    >> Share

  197. COKER TR, Cheng TL, Ybarra M
    Addressing the Long-term Effects of the COVID-19 Pandemic on Children and Families: A Report From the National Academies of Sciences, Engineering, and Medicine.
    JAMA. 2023 Mar 16. doi: 10.1001/jama.2023.4371.
    >> Share

  198. HARRIS E
    FDA Approves First Over-the-counter Combined COVID-19 and Flu Test.
    JAMA. 2023 Mar 8. doi: 10.1001/jama.2023.3192.
    >> Share

  199. SURAN M
    Long COVID Linked With Unemployment in New Analysis.
    JAMA. 2023;329:701-702.
    >> Share

  200. HARRIS E
    Meta-analysis: COVID-19 Infection Protects Against Severe Disease.
    JAMA. 2023 Mar 1. doi: 10.1001/jama.2023.2885.
    >> Share

  201. HARRIS E
    Prior COVID-19 Infection Tied to Lasting Lung Abnormalities.
    JAMA. 2023 Mar 1. doi: 10.1001/jama.2023.2886.
    >> Share

  202. RUBIN R
    Highlights From CROI, the Conference on Retroviruses and Opportunistic Infections-Postexposure Prophylaxis for Sexually Transmitted Infections, a New Protease Inhibitor for COVID-19, Goals for Preventing HIV Transmission, and More.
    JAMA. 2023 Mar 1. doi: 10.1001/jama.2023.0158.
    >> Share

    February 2023
  203. NEPRASH HT, Golberstein E, Ganguli I, Chernew ME, et al
    Association of Evaluation and Management Payment Policy Changes With Medicare Payment to Physicians by Specialty.
    JAMA. 2023;329:662-669.
    >> Share

  204. ABBASI J
    Bird Flu Has Begun to Spread in Mammals-Here's What's Important to Know.
    JAMA. 2023;329:619-621.
    >> Share

  205. HARRIS E
    Study: No New SARS-CoV-2 Variants in Recent Outbreak in China.
    JAMA. 2023 Feb 22. doi: 10.1001/jama.2023.2089.
    >> Share

  206. HARRIS E
    COVID-19 Vaccination During Pregnancy Protected Infants.
    JAMA. 2023 Feb 22. doi: 10.1001/jama.2023.2098.
    >> Share

  207. LARKIN H
    National Academies: Expand US Wastewater Disease Surveillance.
    JAMA. 2023;329:531.
    >> Share

  208. NAGGIE S, Boulware DR, Lindsell CJ, Stewart TG, et al
    Effect of Higher-Dose Ivermectin for 6 Days vs Placebo on Time to Sustained Recovery in Outpatients With COVID-19: A Randomized Clinical Trial.
    JAMA. 2023 Feb 20:e231650. doi: 10.1001/jama.2023.1650.
    >> Share

  209. BIBBINS-DOMINGO K, Malani PN
    At a Higher Dose and Longer Duration, Ivermectin Still Not Effective Against COVID-19.
    JAMA. 2023 Feb 20. doi: 10.1001/jama.2023.1922.
    >> Share

  210. HARRIS E
    NIH Considers Lessons Learned During COVID-19 Pandemic.
    JAMA. 2023 Feb 15. doi: 10.1001/jama.2023.1553.
    >> Share

  211. HARRIS E
    Most COVID-19 Deaths Worldwide Were Among Older People.
    JAMA. 2023 Feb 15. doi: 10.1001/jama.2023.1554.
    >> Share

  212. RUBIN R
    Questions Remain About What SARS-CoV-2 Variants Should Go Into the Annual COVID-19 Vaccines Proposed by the FDA.
    JAMA. 2023 Feb 15. doi: 10.1001/jama.2022.22285.
    >> Share

  213. HARRIS E
    Updated COVID-19 Guidance for People Who Are Immunocompromised.
    JAMA. 2023 Feb 8. doi: 10.1001/jama.2023.1176.
    >> Share

  214. LARKIN H
    Newly Discovered Host-Cell Factor Could Be a COVID-19 Treatment Target.
    JAMA. 2023 Feb 1. doi: 10.1001/jama.2023.0748.
    >> Share

  215. LARKIN H
    High COVID-19 Rates Prompt Call for Better Nursing Home Protections.
    JAMA. 2023 Feb 1. doi: 10.1001/jama.2023.0740.
    >> Share

  216. LARKIN H
    Hybrid Immunity More Protective Than Prior SARS-CoV-2 Infection Alone.
    JAMA. 2023 Feb 1. doi: 10.1001/jama.2023.0743.
    >> Share

    October 2021
  217. RADWANY S
    Our Best Judgment.
    JAMA. 2021;326:1373-1374.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016